Top U.S. cholesterol-lowering drugs by revenue market share 2013

This statistic shows the top ten HMG-CoA reductase inhibitors based on U.S. revenue market share in 2013. In that year, Livalo was among the leading HMG-CoA reductase inhibitors generating a market share of 1.9 percent based on revenues in the United States. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.

Top HMG-CoA reductase inhibitors based on U.S. revenue market share in 2013

Market share
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2014

Region

United States

Survey time period

2013

Supplementary notes

HMG-CoA reductase: 3-hydroxy-3-methyl-glutaryl-CoA reductase. A class of drugs for cholesterol lowering.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.